Bristol-Meyers Squibb recalls injectable Coumadin
Angela Marshall | July 08, 2014 | Cardiovascular Business | Patient Care

Bristol-Meyers Squibb issued a voluntary recall of Coumadin for injection after particulate matter was found in unreleased samples.

The company said the recall is precautionary and involves few lots. Oral Coumadin (Coumadin tablets) is not affected by this recall.

Injection of particulate matter can cause fatal adverse reactions, including embolism. Bristol-Meyers Squibb has advised discontinued use for any injectable Coumadin that is part of the affected lots distributed to hospitals and pharmacies between November 2011 and January 2014.

Effected six lots of COUMADIN FOR INJECTION (warfarin sodium) 5 mg single-use vials include 201125, 210026, 201127, 201228, 201229, and 201230 with expiration dates from September 2014 through September 2015.

Physicians and providers can contact Bristol-Meyer Squibb’s recall vendor GENCO to return affected lots.

Angela Marshall

Related Content

Cardiologist moves to Mississippi to fight back against PAD and limit amputations
On-pump vs. off-pump CABG: No difference in long-term mortality, meta-analysis confirms
Peripheral artery disease is out of control in many rural, low income communities
The many benefits of using low-cost CT coronary calcium scoring to screen patients
Early feasibility study for implantable heart failure monitor moves forward 
Using 'magic' to calm pediatric patients during imaging exams

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup